Budesonide; Formoterol Fumarate Patent Expiration
Budesonide; Formoterol Fumarate is used for managing chronic obstructive pulmonary disease (COPD) symptoms. It was first introduced by Astrazeneca Pharmaceuticals Lp
Budesonide; Formoterol Fumarate Patents
Given below is the list of patents protecting Budesonide; Formoterol Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Symbicort Aerosphere | US10716753 | Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems | May 28, 2030 | Astrazeneca |
| Symbicort Aerosphere | US9415009 | Compositions, methods and systems for respiratory delivery of two or more active agents | May 28, 2030 | Astrazeneca |
Budesonide; Formoterol Fumarate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List